Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Genetic studies reveal diversity of early human populations – and pin down when we left Africa

Research

Humans are a success story like no other. We are now living in the “Anthropocene” age, meaning much of what we see around us has been made or influenced by people. Amazingly, all humans alive today – from the inhabitants of Tierra del Fuego on the southern tip of the Americas to the Sherpa in the Himalayas and the mountain tribes of Papua New Guinea – came from one common ancestor.

We know that our lineage arose in Africa and quickly spread to the four corners of the globe. But the details are murky. Was there just one population of early humans in Africa at the time? When exactly did we first leave the continent and was there just one exodus? Some scientists believe that all non-Africans today can trace their ancestry back to a single migrant population, while others argue that there were several different waves of migration out of Africa.

Now, three new studies mapping the genetic profiles of more than 200 populations across the world, published in Nature, have started to answer some of these questions.

Read more on The Conversation website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

Cognitive behavioural therapy: we discovered a data gap on its effectiveness for different ethnic groups

General Research

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.